The article describes an innovation in medicine that uses artificial intelligence to create virtual patients, allowing medication testing to be done significantly faster than traditional methods. The main advantage highlighted is the drastic reduction in time needed to form patient cohorts for clinical trials.
According to the article, the traditional process of recruiting approximately 1,100 real patients for a clinical trial can take up to three years. This long period represents one of the biggest challenges in developing new medications, delaying the availability of treatments for patients.
In contrast, artificial intelligence can create a virtual cohort with 500 patients in just 30 seconds. This unprecedented speed allows for a drastic acceleration of the medication testing phase, potentially revolutionizing how clinical trials are conducted.
AI technology thus offers an efficient alternative to recruiting real patients, potentially reducing drug development time from years to just seconds in the cohort formation phase, which represents a paradigm shift in the clinical research process.
